Abstract:Corneal neovascularization (CNV) is an ocular pathological change that results from an imbalance between angiogenic factors and antiangiogenic factors as a result of various ocular insults, including infection, inflammation, hypoxia, trauma, corneal degeneration, and corneal transplantation. Current clinical strategies for the treatment of CNV include pharmacological treatment and surgical intervention. Despite some degree of success, the current treatment strategies are restricted by limited efficacy, adverse effects, and a short duration of action. Recently, gene-based antiangiogenic therapy has become an emerging strategy that has attracted considerable interest. However, potential complications with the use of viral vectors, such as potential genotoxicity resulting from long-term expression and nonspecific targeting, cannot be ignored. The use of ocular nanosystems (ONS) based on nanotechnology has emerged as a great advantage in ocular disease treatment during the last two decades. The potential functions of ONS range from nanocarriers, which deliver drugs and genes to target sites in the eye, to therapeutic agents themselves. Various preclinical studies conducted to date have demonstrated promising results of the use of ONS in the treatment of CNV. In this review, we provide an overview of CNV and its current therapeutic strategies and summarize the properties and applications of various ONS related to the treatment of CNV reported to date. Our goal is to provide a comprehensive review of these considerable advances in ONS in the field of CNV therapy over the past two decades to fill the gaps in previous related reports. Finally, we discuss existing challenges and future perspectives of the use of ONS in CNV therapy, with the goal of providing a theoretical contribution to facilitate future practical growth in the area.

Progress on mechanism and therapeutic of corneal neovascularization

Recent Advance on Pathogenesis of Choroidal Neovascularization

Contribution of VEGF and PEDF to Choroidal Angiogenesis: A Need for Balanced Expressions

Review of the Progress in Corneal Neovascularization Animal Models

Progress on the establishment of corneal neovascularization animal model

Research progress on the correlation between corneal neovascularization and lymphangiogenesis (Review)

Histone Methylation Regulates Neutrophil Extracellular Traps to Attenuate Corneal Neovascularization

Research Progress in Corneal Neovascularization and Microenvironment

Corneal neovascularization and treatment

An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization

Nanoparticle-mediated corneal neovascularization treatments: Toward new generation of drug delivery systems

Restoration of corneal epithelial barrier function: a possible target for corneal neovascularization

Management of corneal neovascularization: Current and emerging therapeutic approaches

Angiogenesis and lymphangiogenesis in corneal transplantation–A review

Progress in Research on the Role of FGF in the Formation and Treatment of Corneal Neovascularization

Gene-based therapeutic tools in the treatment of Cornea Disease.

Anti-VEGF Treatment for Myopic Choroid Neovascularization: from Molecular Characterization to Update on Clinical Application

Advances in Culture, Expansion and Mechanistic Studies of Corneal Endothelial Cells: a Systematic Review

Up-to-date molecular medicine strategies for management of ocular surface neovascularization

A Synergistic Therapy with Antioxidant and Anti‐VEGF: Towards Its Safe and Effective Elimination for Corneal Neovascularization

Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno‐associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation